Results 101 to 110 of about 57,246 (250)
Plant-based vaccines against viral hepatitis: A panoptic review
The traditional vaccines against hepatitis have been instrumental in reducing the incidence of some types of viral hepatitis; however, the need for cost-effective, easily distributable, and needle-free vaccine alternatives has led to the exploration of plant-based vaccines.
Reka, Devanathan +1 more
openaire +2 more sources
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley +15 more
wiley +1 more source
Background & Aims: Liver diseases resulting from chronic HBV infection are a significant cause of morbidity and mortality. Vaccines that elicit T-cell responses capable of controlling the virus represent a treatment strategy with potential for long ...
Anna H. Mooney +22 more
doaj +1 more source
[Epidemiologic aspects of viral hepatitis A and vaccination].
Epidemiological problems connected with hepatitis A in twentieth century and in the first years of twenty-first were mentioned with special attention of self-limiting of cases in the periods of very high, high, medium, low and very low endemicity. Decreasing of percentage of immunised persons was observed especially among children and young persons. It
openaire +1 more source
The Role of Viruses in the Pathogenesis of Periodontitis
This narrative review aimed to summarize current evidence on the presence and potential pathogenic role of viruses in periodontitis. Design: Narrative Review; Population: Patients with periodontitis; Exposure: Detection of viruses in oral samples (biopsies, saliva, gingival crevicular fluid, subgingival plaque, blood); Outcome: Viral prevalence, load ...
Kim Natalie Stolte +2 more
wiley +1 more source
Viral hepatitis and prevention-current status and future prospects
(Received 12 Aug, 2008; Accepted 3 Dec, 2008) Abstract Viral hepatitis is the most common cause of liver disease in the world. In the past 30 years, highly effective vaccines have become available for two of the five hepatitis viruses, and where ...
Hana Saffar +2 more
doaj
Bacteriophage P22 Virus‐Like Particles as Nanoscale Protein Scaffolds for Plant Synthetic Biology
ABSTRACT Advancing the utility of plant synthetic biology requires the continued development of protein engineering tools. Self‐assembling protein compartments, such as virus‐like particles (VLPs), provide versatile scaffolds for synthetic biology. However, few plant‐expressed VLPs have demonstrated broad amenability to protein engineering, restricting
Maxim D. Harding +5 more
wiley +1 more source
Cross‐Neutralizing and Broadly Neutralizing Human Antibodies Against Nonenveloped Viruses [PDF]
In this review article, Marchand et al. compare cross ‐ and broadly ‐neutralizing human antibodies against non ‐ enveloped viruses from several major families, discussing their structural characteristics, neutralization mechanisms and relevance for the development of antiviral vaccines and therapeutics.
Marchand S, Taouli S, McIlroy D.
europepmc +2 more sources
Antibiotic‐mediated immune modulation in periodontitis
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez +6 more
wiley +1 more source
New developments in the era of viral hepatitis vaccines
Chronic hepatitis B and hepatitis C infections are major health problems in the world. Therefore, prevention of the transmission of the viral infections gets higher priority. Development of hepatitis B vaccines by recombinant technology provide higher prevention rates. However, this success could not be achieved with hepatitis C vaccine.
openaire +1 more source

